screen_shot_2012-08-08_at_16

ABPI appoints UK pharma team to head VBP discussion

pharmafile | August 8, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  ABPI, VBP 

The ABPI has announced the team which will represent the pharma industry in negotiations with the government to agree the new Value-Based Pricing scheme from 2014.

The negotiations will begin in September and the ABPI has chosen a team which is representative of different sizes of companies, as well as the different geographies.  

The team representing ABPI will be:

John Kearney, UK & Ireland general manager of Amgen. He will serve as chair of the team.

Advertisement

Pete Butterfield, executive director, Alliance.

Erik van Snippenberg, general manager & senior VP UK, GSK.

Jon Emms, managing director UK, Pfizer.

Matthew Speers (pictured), managing director, UK and Ireland, UCB.

They will be supported by an ABPI team led by Alison Clough, commercial director.

Related Content

pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

brexit-hintergrund_web

UK life sciences industry does not want no-deal Brexit, says ABPI Chief

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …

mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …

The Gateway to Local Adoption Series

Latest content